Tatsuaki Matsubara Selected Research

Tatsuaki Matsubara Research Topics

Disease

16	Myocardial Infarction 10/2021 - 10/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 08/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2004
9	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021 - 06/2005
8	Periodontitis 11/2020 - 04/2012
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018 - 03/2007
5	Acute Coronary Syndrome 01/2017 - 10/2010
5	Atherosclerosis 07/2016 - 01/2008
5	Inflammation (Inflammations) 07/2016 - 12/2009
5	Stable Angina 10/2014 - 03/2006
4	Hypertension (High Blood Pressure) 05/2022 - 02/2002
4	Heart Failure 10/2021 - 08/2005
4	ST Elevation Myocardial Infarction 06/2021 - 08/2005
3	Alveolar Bone Loss 11/2020 - 04/2012
3	Obesity 12/2018 - 03/2011
3	Neointima 12/2017 - 01/2013
3	Atherosclerotic Plaque (Atheroma) 01/2017 - 01/2008
3	Chronic Renal Insufficiency 11/2016 - 03/2012
3	Peripheral Arterial Disease 03/2013 - 07/2008
3	Insulin Resistance 11/2012 - 01/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2012 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2012 - 10/2008
3	Hyperlipidemias (Hyperlipidemia) 01/2009 - 11/2006
3	Angina Pectoris 05/2007 - 01/2004
2	Stroke (Strokes) 10/2021 - 08/2010
2	Hemorrhage 06/2021 - 05/2013
2	Body Weight (Weight, Body) 08/2020 - 12/2010
2	Thrombosis (Thrombus) 12/2017 - 01/2013
2	Ischemia 05/2013 - 10/2002
2	Renal Insufficiency (Renal Failure) 12/2012 - 01/2008
2	Glucose Intolerance 01/2012 - 08/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2010 - 01/2007
2	Pathologic Constriction (Stenosis) 01/2010 - 03/2007
2	Reperfusion Injury 11/2006 - 02/2006
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2021
1	Tooth Loss 01/2021
1	Edema (Dropsy) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Diabetes Complications 01/2021
1	Bone Resorption 01/2020
1	Gout 01/2019
1	Arthritis (Polyarthritis) 01/2019

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 12/2017 - 03/2007
6	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2011
5	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2012
5	CytokinesIBA 01/2021 - 10/2011
5	MetalsIBA 10/2013 - 03/2006
5	Sirolimus (Rapamycin)FDA Link 10/2013 - 01/2008
5	C-Reactive ProteinIBA 05/2013 - 12/2009
4	Therapeutic UsesIBA 01/2021 - 10/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2008
4	Nicorandil (SG 75)IBA 05/2007 - 08/2005
3	AdipokinesIBA 12/2018 - 12/2014
3	AdiponectinIBA 11/2012 - 03/2011
2	Amlodipine (Norvasc)FDA LinkGeneric 05/2022 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2020
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2020 - 07/2016
2	Blood Glucose (Blood Sugar)IBA 08/2020 - 02/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 07/2016
2	3-nitrotyrosineIBA 10/2017 - 04/2012
2	Nylons (Nylon)IBA 10/2017 - 04/2012
2	Messenger RNA (mRNA)IBA 03/2014 - 04/2012
2	IndicanIBA 03/2013 - 02/2013
2	Pharmaceutical PreparationsIBA 01/2013 - 08/2010
2	Indicators and Reagents (Reagents)IBA 02/2012 - 10/2008
2	Atorvastatin (Lipitor)FDA Link 01/2012 - 12/2010
2	oxidized low density lipoproteinIBA 01/2012 - 12/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 03/2011 - 08/2008
2	Cilostazol (Pletal)FDA LinkGeneric 01/2010 - 07/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 11/2006
2	MagnesiumIBA 06/2008 - 11/2003
2	Angiotensin Receptor AntagonistsIBA 11/2007 - 11/2006
2	Antihypertensive Agents (Antihypertensives)IBA 11/2006 - 01/2004
1	ChemokinesIBA 01/2021
1	Insulin (Novolin)FDA Link 11/2020
1	Liraglutide FDA Link 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	N 30IBA 01/2020
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Conditioned Culture MediaIBA 09/2019
1	Uric Acid (Urate)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2017

Therapy/Procedure

20	Percutaneous Coronary Intervention 06/2021 - 08/2005
13	Stents 12/2017 - 01/2008
10	Renal Dialysis (Hemodialysis) 01/2016 - 01/2007
9	Transplantation 01/2021 - 06/2005
8	Drug-Eluting Stents 12/2017 - 12/2009
7	Therapeutics 08/2020 - 02/2006
6	Ligation 11/2020 - 04/2012
4	Patient Readmission 10/2021 - 08/2005
4	Stem Cell Transplantation 01/2021 - 12/2017
2	Glycemic Control 01/2021 - 05/2013
1	Transcatheter Aortic Valve Replacement 10/2021
1	Cell Transplantation 12/2017